Mangoceuticals, Inc. (MGRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.31M | -1.08M | -1.24M | -1.26M | -2.27M | -1.13M | -1.17M | -1.58M | -991.13K | -1.7M | -1.71M | -1.78M |
| Operating CF Margin % | -1932.31% | -1142.18% | -1473.38% | -747.4% | -2081.11% | -1073.26% | -874.15% | -966.66% | -462.94% | -694.73% | -697.81% | -1260.71% |
| Operating CF Growth % | 42.35% | 4.59% | -6.47% | 20.34% | -129.51% | 33.47% | 31.85% | 11.42% | 45.24% | -161.37% | -184.96% | -2185.67% |
| Net Income | -3.4M | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M |
| Depreciation & Amortization | 277.06K | 448.15K | 301.47K | 836.23K | 414.99K | 721.79K | -28.75K | 3.21K | 6.22K | 6.29K | 6.29K | 6.22K |
| Stock-Based Compensation | 1.09M | -33.47K | 0 | 50.98K | 1.05M | 50.98K | 108.76K | 50.98K | 37.97K | 429.08K | 66.84K | 64.27K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 724.62K | 1.34M | 6.51M | 3.19M | 959.72K | -7.87K | 744.58K | 1.05M | 420.55K | 358.9K | 84.75K | 378.77K |
| Working Capital Changes | 0 | -62.66K | -432.29K | 80.96K | 144.52K | 54.13K | 9.27K | -289.57K | 915.8K | 76.03K | -69.17K | 55.74K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.49K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -5.29K | 806 | 433 | 4.05K | 3.08K | 1.91K | -23.49K |
| Change in Payables | 113.12K | -98.17K | -276.66K | 89.82K | 340.68K | 83.54K | 35.31K | -332.3K | 910.18K | 51.71K | -41.15K | 99.41K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65K | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -65K | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 0% | - | - | - | 48.74% | 0% | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 65K | 65K | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 2.08M | 1.62M | 1.28M | 2.29M | 1.12M | 750K | 1.99M | 267.5K | 1.2M | 0 | 935.3K |
| Debt Issued (Net) | 0 | -131.5K | 0 | 600K | 0 | -37.5K | 0 | 100K | 87.5K | 0 | 0 | -89.2K |
| Equity Issued (Net) | 0 | 2.21M | 1.62M | -619.22K | 2.29M | 1.16M | 750K | 388.27K | 180K | 1.2M | 0 | 1.02M |
| Dividends Paid | 0 | 0 | 0 | -588K | 0 | -802.11K | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 1.89M | 0 | 802.11K | 0 | 1.5M | 0 | 0 | 0 | 0 |
| Net Change in Cash | 0 | 1.01M | 380.26K | 24.52K | 17.84K | -15.26K | -416.33K | 474.94K | -723.7K | -497.74K | -1.71M | -843.72K |
| Free Cash Flow | -1.31M | -1.08M | -1.24M | -1.26M | -2.27M | -1.13M | -1.17M | -1.58M | -991.13K | -1.7M | -1.71M | -1.78M |
| FCF Margin % | -1932.31% | -1142.18% | -1473.38% | -747.4% | -2081.11% | -1073.26% | -874.15% | -966.67% | -462.94% | -694.73% | -697.81% | -1259.6% |
| FCF Growth % | 42.35% | 4.59% | -6.47% | 20.34% | -129.51% | 33.47% | 31.85% | 11.34% | 45.34% | -146% | -183.76% | -2183.67% |
| FCF per Share | -0.13 | -0.11 | -0.11 | -0.13 | -0.50 | -0.35 | -0.58 | -0.91 | -0.65 | -1.31 | -1.61 | -1.60 |
| FCF Conversion (FCF/Net Income) | 0.39x | 0.39x | 0.16x | 0.23x | 0.47x | 0.58x | 0.58x | 0.66x | 0.42x | 0.66x | 0.95x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |